Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
   
Ask the Experts About

Managing Side Effects of HIV TreatmentManaging Side Effects of HIV Treatment
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


azt
Jul 14, 2002

What is your opinion of combining azt with viread if one has 3tc resistance making combivir not an option?Since the toxcity profile is very similar for 3tc and viread(very low side effects)I thought this might be a viable option to use as the basis for constructing a pi sparing reg with viramune.Won't entertain zerit again,because it took me three long years to recover from lipotropy(it was moderate not severe)but with alot of hard work (diet,exercise,supplements,etc)and problably a dose of luck there is no evidence today of any lipotrophy.What is your feeling on azt,viread and viramune as a triple?Thank you...

Response from Dr. Henry

3TC resistance actually makes both AZT and tenofovir work better is some cases so either of those drugs are OK to use with 3TC (or both). KH



Previous
Barcelona
Next
t-20

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement